Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
10.30B
Market cap10.30B
Price-Earnings ratio
29.12
Price-Earnings ratio29.12
Dividend yield
Dividend yield
Average volume
1.42M
Average volume1.42M
High today
$148.69
High today$148.69
Low today
$145.07
Low today$145.07
Open price
$146.87
Open price$146.87
Volume
232.36K
Volume232.36K
52 Week high
$354.88
52 Week high$354.88
52 Week low
$126.40
52 Week low$126.40

Stock Snapshot

The current Insulet(PODD) stock price is $148.57, with a market capitalization of 10.3B. The stock trades at a price-to-earnings (P/E) ratio of 29.12.

On 2026-08-21, Insulet(PODD) stock traded between a low of $145.07 and a high of $148.69. Shares are currently priced at $148.57, which is +2.4% above the low and -0.1% below the high.

The Insulet(PODD)'s current trading volume is 232.36K, compared to an average daily volume of 1.42M.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $126.40.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $126.40.

PODD News

MarketWatch 3d
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch

...

Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 6d
Does Stronger Q2 Results And Higher Guidance Change The Bull Case For Insulet?

In August 2026, Insulet Corporation reported second-quarter 2026 results showing revenue of US$801.7 million and net income of US$95.0 million, with diluted ear...

Does Stronger Q2 Results And Higher Guidance Change The Bull Case For Insulet?

Analyst ratings

57%

of 28 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.